Literature DB >> 4924592

Hepatic fibrosis. Correlation of biochemical and morphologic investigations.

H Popper, S Uenfriend.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4924592     DOI: 10.1016/s0002-9343(70)80135-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  65 in total

1.  Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism.

Authors:  Songbai Lin; Neeraj K Saxena; Xiaokun Ding; Lance L Stein; Frank A Anania
Journal:  Mol Endocrinol       Date:  2006-08-24

2.  Contribution to the study of septal fibrosis of the liver.

Authors:  Z A Andrade
Journal:  Int J Exp Pathol       Date:  1991-10       Impact factor: 1.925

3.  Collagenase in experimental carbon tetrachloride cirrhosis of the liver.

Authors:  I Montfort; R Pérez-Tamayo
Journal:  Am J Pathol       Date:  1978-08       Impact factor: 4.307

4.  The synthesis of total and specific glycosaminoglycans during development of experimental liver cirrhosis.

Authors:  A M Gressner; H Pazen; H Greiling
Journal:  Experientia       Date:  1977-10-15

5.  Abnormal liver function in chronic hypervitaminosis A.

Authors:  G C Farrell; P S Bhathal; L W Powell
Journal:  Am J Dig Dis       Date:  1977-08

6.  Pathology of collagen degradation. A review.

Authors:  R Pérez-Tamayo
Journal:  Am J Pathol       Date:  1978-08       Impact factor: 4.307

7.  Biochemical and immunochemical study of lysyl oxidase in experimental hepatic fibrosis in the rat.

Authors:  R C Siegel; K H Chen; J S Greenspan; J M Aguiar
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

Review 8.  Connective tissue components of the normal and fibrotic human liver. II. Clinical aspects.

Authors:  G Pott; J Rauterberg; B Voss; U Gerlach
Journal:  Klin Wochenschr       Date:  1982-01-04

9.  CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients.

Authors:  E A Sotaniemi; A Rautio; M Bäckstrom; P Arvela; O Pelkonen
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

10.  [Immunohistochemical characterization of collagen in liver cirrhosis (author's transl)].

Authors:  K Remberger; S Gay; P P Fietzek
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.